-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Upgrades Oscar Health to Overweight, Raises Price Target to $35

Benzinga·06/10/2026 13:01:21
Listen to the news
Barclays analyst Andrew Mok upgrades Oscar Health (NYSE:OSCR) from Equal-Weight to Overweight and raises the price target from $30 to $35.